Owens & Minor (OMI) Scheduled to Post Earnings on Friday

Owens & Minor (NYSE:OMIGet Free Report) is scheduled to post its quarterly earnings results before the market opens on Friday, May 3rd. Analysts expect Owens & Minor to post earnings of $0.17 per share for the quarter. Owens & Minor has set its FY 2024 guidance at 1.400-1.700 EPS and its FY24 guidance at $1.40-$1.70 EPS.Individual interested in participating in the company’s earnings conference call can do so using this link.

Owens & Minor (NYSE:OMIGet Free Report) last posted its quarterly earnings data on Tuesday, February 20th. The company reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.03. The business had revenue of $2.66 billion during the quarter, compared to analyst estimates of $2.67 billion. Owens & Minor had a positive return on equity of 11.62% and a negative net margin of 0.40%. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period last year, the company earned $0.28 EPS. On average, analysts expect Owens & Minor to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Owens & Minor Price Performance

NYSE:OMI opened at $24.12 on Friday. The firm has a market capitalization of $1.85 billion, a price-to-earnings ratio of -44.67, a PEG ratio of 0.81 and a beta of 0.43. Owens & Minor has a 1 year low of $13.34 and a 1 year high of $28.35. The business has a 50 day simple moving average of $25.16 and a 200-day simple moving average of $21.05. The company has a debt-to-equity ratio of 2.05, a current ratio of 1.11 and a quick ratio of 0.52.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on OMI. SVB Leerink began coverage on Owens & Minor in a research note on Monday, February 26th. They set a “market perform” rating and a $24.00 price target for the company. Leerink Partnrs reissued a “market perform” rating on shares of Owens & Minor in a research note on Monday, February 26th. Barclays raised their price target on Owens & Minor from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 21st. Robert W. Baird raised their price target on Owens & Minor from $24.00 to $28.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 10th. Finally, StockNews.com raised Owens & Minor from a “hold” rating to a “buy” rating in a research note on Wednesday, February 21st. One investment analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $23.29.

View Our Latest Stock Analysis on OMI

Insider Buying and Selling

In other Owens & Minor news, SVP Jonathan A. Leon sold 5,000 shares of Owens & Minor stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $24.84, for a total value of $124,200.00. Following the transaction, the senior vice president now owns 84,673 shares in the company, valued at $2,103,277.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Owens & Minor news, SVP Michael Wayne Lowry sold 10,000 shares of the stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $25.00, for a total value of $250,000.00. Following the completion of the sale, the senior vice president now directly owns 71,654 shares in the company, valued at $1,791,350. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Jonathan A. Leon sold 5,000 shares of the stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $24.84, for a total transaction of $124,200.00. Following the completion of the transaction, the senior vice president now directly owns 84,673 shares of the company’s stock, valued at $2,103,277.32. The disclosure for this sale can be found here. 3.59% of the stock is currently owned by company insiders.

Owens & Minor Company Profile

(Get Free Report)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Further Reading

Earnings History for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.